Hangzhou Tigermed Consulting Working Capital to Net Assets Ratio
Hangzhou Tigermed Consulting working capital to net assets ratio. Hangzhou Tigermed Consulting (300347) has a Working Capital to Net Assets ratio of 15.3% as of March 2026. Working capital of CN¥3.75 Billion (current assets of CN¥6.63 Billion minus current liabilities of CN¥2.88 Billion) is measured against net assets of CN¥24.56 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Hangzhou Tigermed Consulting's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hangzhou Tigermed Consulting (2009–2025)
Working capital to net assets ratio of Hangzhou Tigermed Consulting from 2009 to 2025. This chart shows how Hangzhou Tigermed Consulting's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the ratio stands at 15.3%, reflecting working capital of CN¥3.75 Billion against net assets of CN¥24.56 Billion CNY. See defensive interval ratio of Hangzhou Tigermed Consulting to measure how many days the company can operate on defensive assets alone.
Hangzhou Tigermed Consulting Working Capital to Net Assets Ratio by Year (2009–2025)
Hangzhou Tigermed Consulting working capital to net assets ratio by year from 2009 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Hangzhou Tigermed Consulting from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 300347 total asset value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 13.8% | CN¥3.34 Billion | CN¥24.26 Billion | CN¥6.18 Billion | CN¥2.84 Billion | ▲ +2.8 pp |
| 2024 | 11.0% | CN¥2.64 Billion | CN¥24.06 Billion | CN¥6.30 Billion | CN¥3.66 Billion | ▼ -18.5 pp |
| 2023 | 29.5% | CN¥7.21 Billion | CN¥24.45 Billion | CN¥11.34 Billion | CN¥4.14 Billion | ▼ -3.1 pp |
| 2022 | 32.5% | CN¥7.38 Billion | CN¥22.68 Billion | CN¥11.11 Billion | CN¥3.73 Billion | ▼ -8.4 pp |
| 2021 | 41.0% | CN¥8.44 Billion | CN¥20.61 Billion | CN¥10.85 Billion | CN¥2.41 Billion | ▼ -17.9 pp |
| 2020 | 58.8% | CN¥10.51 Billion | CN¥17.86 Billion | CN¥11.65 Billion | CN¥1.14 Billion | ▲ +30.6 pp |
| 2019 | 28.3% | CN¥1.56 Billion | CN¥5.52 Billion | CN¥3.37 Billion | CN¥1.81 Billion | ▲ +16.5 pp |
| 2018 | 11.8% | CN¥384.94 Million | CN¥3.27 Billion | CN¥1.65 Billion | CN¥1.26 Billion | ▼ -10.1 pp |
| 2017 | 21.9% | CN¥612.42 Million | CN¥2.80 Billion | CN¥1.35 Billion | CN¥733.17 Million | ▼ -14.0 pp |
| 2016 | 35.8% | CN¥659.03 Million | CN¥1.84 Billion | CN¥1.09 Billion | CN¥435.78 Million | ▲ +15.4 pp |
| 2015 | 20.4% | CN¥217.43 Million | CN¥1.07 Billion | CN¥688.67 Million | CN¥471.24 Million | ▼ -23.3 pp |
| 2014 | 43.6% | CN¥400.21 Million | CN¥916.90 Million | CN¥786.98 Million | CN¥386.77 Million | ▼ -39.6 pp |
| 2013 | 83.3% | CN¥629.02 Million | CN¥755.14 Million | CN¥681.89 Million | CN¥52.87 Million | ▼ -6.2 pp |
| 2012 | 89.5% | CN¥621.58 Million | CN¥694.32 Million | CN¥660.10 Million | CN¥38.52 Million | ▲ +17.3 pp |
| 2011 | 72.2% | CN¥105.42 Million | CN¥146.03 Million | CN¥143.58 Million | CN¥38.16 Million | ▲ +2.6 pp |
| 2010 | 69.6% | CN¥66.67 Million | CN¥95.79 Million | CN¥89.92 Million | CN¥23.25 Million | ▲ +36.9 pp |
| 2009 | 32.7% | CN¥14.46 Million | CN¥44.26 Million | CN¥37.59 Million | CN¥23.13 Million | — |